CL2015003104A1 - Compositions and methods for encapsulating vaccines for oral vaccination and booster vaccination in fish and other animals - Google Patents

Compositions and methods for encapsulating vaccines for oral vaccination and booster vaccination in fish and other animals

Info

Publication number
CL2015003104A1
CL2015003104A1 CL2015003104A CL2015003104A CL2015003104A1 CL 2015003104 A1 CL2015003104 A1 CL 2015003104A1 CL 2015003104 A CL2015003104 A CL 2015003104A CL 2015003104 A CL2015003104 A CL 2015003104A CL 2015003104 A1 CL2015003104 A1 CL 2015003104A1
Authority
CL
Chile
Prior art keywords
vaccination
fish
vaccines
encapsulating
animals
Prior art date
Application number
CL2015003104A
Other languages
Spanish (es)
Inventor
Moti Harel
Brian Carpenter
Original Assignee
Advance Bionutrition Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46514232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015003104(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/466,279 external-priority patent/US8778384B2/en
Application filed by Advance Bionutrition Corp filed Critical Advance Bionutrition Corp
Publication of CL2015003104A1 publication Critical patent/CL2015003104A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSICIÓN DE AGENTE INMUNOGÉNICO ENCAPSULADO PARA ENTREGA ORAL; MÉTODO DE PREPARACIÓN; Y USO PARA PREVENIR ANEMIA INFECCIOSA DEL SALMON (ISA) Y SEPTICEMIA RICKETTSIAL SALMONIDEA (SRS) EN PECES (DIVISIONAL DE SOL. N° 1995-12).COMPOSITION OF IMMUNOGENIC AGENT ENCAPSULATED FOR ORAL DELIVERY; PREPARATION METHOD; AND USE TO PREVENT SALMON INFECTIOUS ANEMIA (ISA) AND SALMONIDEA RICKETTSIAL SEPTICEMY (SRS) IN FISH (SOL DIVISION No. 1995-12).

CL2015003104A 2012-05-08 2015-10-21 Compositions and methods for encapsulating vaccines for oral vaccination and booster vaccination in fish and other animals CL2015003104A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/466,279 US8778384B2 (en) 2008-03-24 2012-05-08 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals

Publications (1)

Publication Number Publication Date
CL2015003104A1 true CL2015003104A1 (en) 2016-06-24

Family

ID=46514232

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2012001995A CL2012001995A1 (en) 2012-05-08 2012-07-18 Oral composition of an immunogenic agent; method for preparing said composition; method of vaccination or oral reinforcement of an animal against a pathogen
CL2015003104A CL2015003104A1 (en) 2012-05-08 2015-10-21 Compositions and methods for encapsulating vaccines for oral vaccination and booster vaccination in fish and other animals

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2012001995A CL2012001995A1 (en) 2012-05-08 2012-07-18 Oral composition of an immunogenic agent; method for preparing said composition; method of vaccination or oral reinforcement of an animal against a pathogen

Country Status (5)

Country Link
EP (1) EP2662074B1 (en)
CA (1) CA2783146C (en)
CL (2) CL2012001995A1 (en)
DK (1) DK2662074T3 (en)
ES (1) ES2693539T3 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2015002907A1 (en) * 2015-09-29 2016-06-17 Univ Santiago Chile Oral vaccine against isav comprising chitosan nanoparticles that encapsulate an isa virus virina and chitosan nanoparticles that encapsulate an adjuvant consisting of an DNA that is encoded for the replicase / transcriptase of a salmon alphavirus (replicon), preparation process, method to treat fish infected with isav and method to stimulate the immune response in fish.
WO2017214497A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use
CN110505887A (en) 2017-02-28 2019-11-26 鲁曼特有限公司 Oral negative contrast medium for abdominal CT
CN109172817B (en) * 2018-08-16 2021-10-26 华中农业大学 Preparation method and application of chitosan microspheres of attenuated live vaccine of porcine epidemic diarrhea virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2105129T3 (en) * 2008-03-24 2018-06-16
ES2908047T3 (en) * 2009-03-27 2022-04-27 Intervet Int Bv Microparticle vaccines for oral or nasal vaccination and boosting of animals including fish

Also Published As

Publication number Publication date
CA2783146C (en) 2020-04-07
ES2693539T3 (en) 2018-12-12
EP2662074A1 (en) 2013-11-13
CL2012001995A1 (en) 2012-12-14
CA2783146A1 (en) 2013-11-08
EP2662074B1 (en) 2018-09-26
DK2662074T3 (en) 2018-12-10

Similar Documents

Publication Publication Date Title
CL2015003104A1 (en) Compositions and methods for encapsulating vaccines for oral vaccination and booster vaccination in fish and other animals
CL2019003264A1 (en) Formulations for vaccines against neoplasia and methods for preparing the same. (divisional request 201703151)
MX363529B (en) Outer membrane vesicles.
AR098882A1 (en) DENTAL COMPOSITION THAT INCLUDES ZINC OXIDE AND ZINC CITRATE
CO6331297A2 (en) NEW ADVANCING COMPOSITIONS
BR112015018877A2 (en) METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION, AND IMMUNOGENIC PHARMACEUTICAL COMPOSITION
EA201590491A1 (en) IMMUNOGENIC COMPOSITION
BR112017000313A2 (en) system for providing a buccal treatment composition, buccal treatment composition, method for administering a buccal treatment composition
TR201802380T4 (en) Vaccines containing benzonaphthyridine.
EA202090699A2 (en) COMPOSITIONS CONTAINING A BUFFER, VACCINES THAT CONTAIN COMPOSITIONS CONTAINING A BUFFER, AND THEIR APPLICATION
CL2015001111A1 (en) Adjuvant composition comprising a carbohydrate attached to the chitosan forming a schiff base; vaccine formulation that comprises it; elaboration method; and use of the vaccine.
MX364800B (en) Improved long-acting tilmicosin and use thereof in the treatment of bovine respiratory disease complex (brdc) and in the dry cow period.
PH12015501716B1 (en) Anti-mycoplasma spp. subunit vaccine
MX358782B (en) Expression of chimeric ksac protein and method of producing soluble proteins by high pressure.
UY35848A (en) TIENOPIRIMIDINS
MX349657B (en) Protein matrix vaccine compositions including polycations.
AR089995A1 (en) ROTAVIRUS SUBUNITIES VACCINES, METHODS OF PREPARATION AND USE OF THE SAME
MX2015017257A (en) Compositions and methods of immunizing against c. difficile.
MX2015010486A (en) Chewable composition for oral administration and process for preparing thereof.
BR112013019924A8 (en) COMPOSITIONS FOR ORAL CARE
CL2013003588A1 (en) Pharmaceutical composition in the form of an oral suspension comprising as active ingredient a fraction of flavonoid and as an excipient xanthan gum in the amount of 0.30% w / w to 0.60% w / w; use for the treatment of venous insufficiency.
ZA201602148B (en) Immunogenic formulation containing recombinant live bcg that express antigens of metapneumovirus (hmpv), in a suspension prepared from a lyophilisate, without requiring an adjuvant, suitable for pharmaceutical use
BR112014017923A8 (en) composition; method for producing antibodies; method for producing antiserum; use of microparticles or nanoparticles; and kit
PH12015501251A1 (en) Compositions and methods for treating dental caries
BR112015002984A2 (en) composition, vaccine to protect an animal against infection with leptospira bacteria, and use of citric acid.